Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 184

Similar articles for PubMed (Select 16424444)

1.

Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease.

Barnes NC, Qiu YS, Pavord ID, Parker D, Davis PA, Zhu J, Johnson M, Thomson NC, Jeffery PK; SCO30005 Study Group.

Am J Respir Crit Care Med. 2006 Apr 1;173(7):736-43. Epub 2006 Jan 19.

PMID:
16424444
2.

Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial.

Lapperre TS, Snoeck-Stroband JB, Gosman MM, Jansen DF, van Schadewijk A, Thiadens HA, Vonk JM, Boezen HM, Ten Hacken NH, Sont JK, Rabe KF, Kerstjens HA, Hiemstra PS, Timens W, Postma DS, Sterk PJ; Groningen Leiden Universities Corticosteroids in Obstructive Lung Disease Study Group.

Ann Intern Med. 2009 Oct 20;151(8):517-27.

PMID:
19841453
3.

Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial.

Bourbeau J, Christodoulopoulos P, Maltais F, Yamauchi Y, Olivenstein R, Hamid Q.

Thorax. 2007 Nov;62(11):938-43. Epub 2007 Jun 8.

4.

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.

Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA; INSPIRE Investigators.

Am J Respir Crit Care Med. 2008 Jan 1;177(1):19-26. Epub 2007 Oct 4.

PMID:
17916806
5.

A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD.

Donohue JF, Kalberg C, Emmett A, Merchant K, Knobil K.

Treat Respir Med. 2004;3(3):173-81.

PMID:
15219176
6.

Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease.

Vestbo J, Pauwels R, Anderson JA, Jones P, Calverley P; TRISTSAN study group.

Thorax. 2005 Apr;60(4):301-4.

7.

Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.

Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.

Ann Allergy Asthma Immunol. 2004 Oct;93(4):351-9.

PMID:
15521371
8.

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J; TORCH investigators.

N Engl J Med. 2007 Feb 22;356(8):775-89.

9.

Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.

Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.

Ann Allergy Asthma Immunol. 1999 Mar;82(3):257-65.

PMID:
10094216
10.

The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study.

Hattotuwa KL, Gizycki MJ, Ansari TW, Jeffery PK, Barnes NC.

Am J Respir Crit Care Med. 2002 Jun 15;165(12):1592-6.

PMID:
12070058
11.

Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease.

Mahler DA, Wire P, Horstman D, Chang CN, Yates J, Fischer T, Shah T.

Am J Respir Crit Care Med. 2002 Oct 15;166(8):1084-91.

PMID:
12379552
12.
13.

The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease.

Sin DD, Man SF, Marciniuk DD, Ford G, FitzGerald M, Wong E, York E, Mainra RR, Ramesh W, Melenka LS, Wilde E, Cowie RL, Williams D, Gan WQ, Rousseau R; ABC (Advair, Biomarkers in COPD) Investigators.

Am J Respir Crit Care Med. 2008 Jun 1;177(11):1207-14. doi: 10.1164/rccm.200709-1356OC. Epub 2008 Feb 28.

PMID:
18310480
14.

Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.

Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM.

Am J Respir Crit Care Med. 2008 Aug 15;178(4):332-8. doi: 10.1164/rccm.200712-1869OC. Epub 2008 May 29.

PMID:
18511702
15.

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium.

Ann Intern Med. 2007 Apr 17;146(8):545-55. Epub 2007 Feb 19.

PMID:
17310045
16.

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.

Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson J, Maden C; TRial of Inhaled STeroids ANd long-acting beta2 agonists study group.

Lancet. 2003 Feb 8;361(9356):449-56. Erratum in: Lancet. 2003 May 10;361(9369):1660.

PMID:
12583942
17.

The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.

Hanania NA, Darken P, Horstman D, Reisner C, Lee B, Davis S, Shah T.

Chest. 2003 Sep;124(3):834-43.

PMID:
12970006
18.

The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD.

Zheng JP, Yang L, Wu YM, Chen P, Wen ZG, Huang WJ, Shi Y, Wang CZ, Huang SG, Sun TY, Wang GF, Xiong SD, Zhong NS.

Chest. 2007 Dec;132(6):1756-63. Epub 2007 Oct 20.

PMID:
17951625
20.

Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.

Boonsawat W, Goryachkina L, Jacques L, Frith L.

Clin Drug Investig. 2008;28(2):101-11.

PMID:
18211118
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk